Dr Prasad Bhukebag｜プラサード・ブケバッグ

Today, we’re launching Gemma 4, our most intelligent open models to date. Built with the same breakthrough technology as Gemini 3, Gemma 4 brings advanced reasoning to your personal hardware and devices. Here’s what Gemma 4 unlocks for developers: — Intelligence-per-parameter: Our 31B (Dense) and 26B (MoE) models deliver state-of-the-art performance for their size, outcompeting models 20x their size on @arena — Commercial flexibility: Released under a permissive Apache 2.0 license for complete developer flexibility and digital sovereignty — Agentic workflows: Native support for function-calling and structured JSON output allows you to build reliable, autonomous agents — Multimodal edge AI: The E2B and E4B models bring native vision, audio, and low latency to mobile and IoT devices — Long-context reasoning: Up to 256K context windows allow you to process entire repositories or large documents in a single prompt Whether you're building global applications in 140+ languages or local-first AI code assistants, Gemma 4 is built to be your foundation. Explore in @GoogleAIStudio or download the weights on @HuggingFace, @Kaggle, and @Ollama.

Be like the promontory against which the waves continually break, but it stands firm and tames the fury of the water around it. - Marcus Aurelius

You risk more when you don't risk..

Good morning @dr_sivaranjani The Public Interest notice put on social media by Kenvue, the makers of Fake ORS™ is a classical case study in "Corporate Health-Washing". Hey @kenvue @JNJNews no one needs your rubbish "hydration products" from a scientific standpoint. So you can go to hell and your products can rot on the shelves for all we care. Stop intimidating physicians and clean up your corporate mess born out of greed. Presenting your products in medical conferences is not scientific evidence, its paid endorsement. So respectfully, F.O. A product that was commercially marketed as ORS for years despite not meeting WHO composition standards, that was formally banned by India's food safety regulator, that had its ban upheld by the Delhi High Court as a "health hazard," and that has now been cosmetically rebranded with a visually similar name, is being presented as a triumph of science-backed innovation. The WHO's own recommendation against the very sweetener used in the reformulated product is dismissed as "unrelated." And the physicians who fought for eight years to protect children from this deception are characterized as "disparaging influencers." Here is a takedown of their sh*tty notice from my side, which you (@dr_sivaranjani) can use in your case against them. 1. "We have shaped the hydration category in India providing consumers with scientifically formulated solutions" This is corporate euphemism for having commercialized a high-sugar beverage that was deceptively branded to resemble WHO-standard ORS for years. The product ORSL was never WHO-compliant ORS. The WHO reduced-osmolarity ORS formula specifies glucose 75 mmol/L (~13.5 g/L), sodium 75 mEq/L, potassium 20 mEq/L, and a total osmolarity of 245 mOsm/L. A product with roughly 8–9 times the glucose concentration of WHO ORS is not a "scientifically formulated solution", it is a sugary beverage that can worsen diarrheal dehydration through osmotic diarrhea. FSSAI found that the labeling and branding of ORSL beverages may mislead consumers into believing the product was a medically approved oral rehydration solution. 2. "In January 2026, we diversified our portfolio into two distinct brands — ORSL (Drug product) and ERZL (Food Product)" This "dual-brand strategy" was not voluntary innovation — it was forced by the FSSAI ban. ORSL has even rebranded to ERZL (the 'e' designed to look similar to 'o' and the 'z' to 's'). The visual similarity between "ERZL" and "ORSL" is not accidental. The product's communication and positioning may create an association with ORS, and references to similarly named products in branding or advertising could reinforce consumer recall and blur the distinction between scientifically approved ORS and commercially marketed electrolyte beverages. A parent who was buying ORSL thinking it was ORS will now see ERZL in the same pharmacy shelf with near-identical packaging and make the same error. This is classic brand continuity engineering designed to circumvent regulatory intent. 3. "Reduced the added sugar content by 87% with 1.4X more electrolytes" — framed as a public health achievement If you reduce sugar by 87% from a baseline of ~110 g/L added sugar, you still have approximately 14 g/L added sugar - and you have now replaced that sugar with sucralose, an artificial sweetener. The framing of "87% reduction" is a mathematical trick: it sounds impressive only because the starting point was absurdly, irresponsibly high. It is like a tobacco company boasting of reducing tar by 87% and expecting public health applause. Furthermore, "1.4X more electrolytes" is vague and scientifically meaningless without specifying which electrolytes, at what concentrations, and whether the resulting osmolarity is appropriate for the claimed indication. An electrolyte drink for "everyday hydration" in a healthy individual is, physiologically speaking, unnecessary - plain water and a normal diet provide adequate electrolytes for non-pathological states. 4. "There is well established scientific and safety assessment of sucralose, which is recognized by Global Health Authorities like Codex, EFSA besides both FSSAI & CDSCO/Indian Pharmacopoeia" This statement cherry-picks regulatory approvals while deliberately ignoring the WHO's own 2023 guideline where especially, this ingredient is not supposed to be part of "healthy hydration." 5. "WHO Guidelines (2023) regarding use of 'non-sugar sweeteners' to reduce the risk of unhealthy weight gain have also been cited out of context and is unrelated to products like WHO ORS and Electrolyte Drinks" This is perhaps the most egregious misrepresentation in the entire notice. The WHO 2023 guideline on NSS is a public health recommendation against the use of non-sugar sweeteners in foods and beverages across the board. This guideline provides evidence-informed guidance on the use of non-sugar sweeteners in adults and children. The guideline explicitly applies to "all synthetic and naturally occurring or modified non-nutritive sweeteners found in manufactured foods and beverages." ERZL is a manufactured beverage containing sucralose. It falls squarely within the scope of this recommendation. Kenvue's argument that this guideline is "unrelated" to electrolyte drinks is scientifically untenable. The WHO did not carve out exceptions for beverages that happen to contain electrolytes. The guideline's scope is defined by the presence of NSS in the product, not by the product's marketing category. 6. "We have been singularly targeted by a few Healthcare Professionals cum influencers in a disparaging and denigrating manner" The healthcare professionals who raised these concerns were exercising their professional duty. Dr. Sivaranjani documented cases over eight years, including a diabetic child from Chennai who was dehydrated despite being given an ORS drink from a tetra pack. It was her advocacy that ultimately led FSSAI to act. Characterizing physician advocacy against misleading health products as "disparagement" is a well-documented corporate strategy (SLAPP: Strategic Lawsuit Against Public Participation) designed to silence public health criticism through legal intimidation. The notice's claim that these professionals are motivated by "commercial benefits" and "increasing followers" is an ad hominem attack that inverts the actual conflict of interest. The commercial benefit accusation is outrageous - the party actually benefitting commercially from the product is the company Kenvue (Johnson & Johnson). 7. "We always recommend our ORSL WHO ORS portfolio to address diarrheal dehydration and ERZL for everyday hydration, respectively" The concept of "everyday hydration" requiring a commercial electrolyte-and-sucralose beverage has no basis in physiology or evidence-based medicine. It is not recommended in any clinical guidelines. Healthy individuals with intact renal function, normal diet, and access to water do not need electrolyte supplementation for everyday activities. "Silent dehydration" - a marketing term promoted by these manufacturers - does not appear in recognized medical literature. This framing medicalizes a normal physiological state to create a market for an unnecessary product. 8. "We had no choice but to take necessary action to safeguard the brand integrity" Sending legal notices to physicians who raise legitimate scientific concerns about a product that was already banned by FSSAI and whose ban was upheld by the Delhi High Court is not "safeguarding brand integrity." It is an attempt to suppress public health advocacy. The timing - sending notices after being forced to rebrand by regulatory action - suggests the motive is to silence documentation of the rebranding's deceptive visual similarity to the original banned product, not to correct misinformation. The science is not on Kenvue's side. The regulatory record is not on Kenvue's side. The public interest is not on Kenvue's side.

This lady tells 1 year of studying quantum physics in under 60 seconds: Quantum physics isn't just science; it's logical spirituality. You don't attract what you want; you align with what you already are. In the quantum field, every version of you already exists, the wealthy you, the happy you, the successful you. Your thoughts and emotions broadcast a frequency that your life mirrors back to you. The quantum field responds to certainty, not begging. Visualization is your most powerful tool because our minds can't distinguish between imagination and reality. Pull your future into the now and recode your past. Everything is accessible right now. You aren't just a person in the universe; you are the universe experiencing itself through you. Go live like the miracle you are!

What happens to the heart when people stop GLP-1 drugs? The short answer: nothing good. New from our team: a study of 330,000+ people in @BMJMedicine 🧵

this is actually insane > be tech guy in australia > adopt cancer riddled rescue dog, months to live > not_going_to_give_you_up.mp4 > pay $3,000 to sequence her tumor DNA > feed it to ChatGPT and AlphaFold > zero background in biology > identify mutated proteins, match them to drug targets > design a custom mRNA cancer vaccine from scratch > genomics professor is “gobsmacked” that some puppy lover did this on his own > need ethics approval to administer it > red tape takes longer than designing the vaccine > 3 months, finally approved > drive 10 hours to get rosie her first injection > tumor halves > coat gets glossy again > dog is alive and happy > professor: “if we can do this for a dog, why aren’t we rolling this out to humans?” one man with a chatbot, and $3,000 just outperformed the entire pharmaceutical discovery pipeline. we are going to cure so many diseases. I dont think people realize how good things are going to get

Announcing Personal Computer. Personal Computer is an always on, local merge with Perplexity Computer that works for you 24/7. It's personal, secure, and works across your files, apps, and sessions through a continuously running Mac mini.

𝘠𝘰𝘶𝘳 𝘥𝘦𝘢𝘵𝘩 𝘸𝘪𝘭𝘭 𝘤𝘰𝘮𝘦 𝘰𝘯 𝘢𝘯 𝘰𝘳𝘥𝘪𝘯𝘢𝘳𝘺 𝘥𝘢𝘺, 𝘪𝘯 𝘵𝘩𝘦 𝘮𝘪𝘥𝘥𝘭𝘦 𝘰𝘧 𝘶𝘯𝘧𝘪𝘯𝘪𝘴𝘩𝘦𝘥 𝘱𝘭𝘢𝘯𝘴, 𝘢𝘯𝘥 𝘵𝘩𝘦 𝘸𝘰𝘳𝘭𝘥 𝘸𝘪𝘭𝘭 𝘤𝘰𝘯𝘵𝘪𝘯𝘶𝘦 𝘸𝘪𝘵𝘩𝘰𝘶𝘵 𝘺𝘰𝘶.

Must Read!

One of the best videos ever made on AI

🇨🇳 A year ago, humanoid robots were struggling with basic movements. At China's 2026 Spring Festival Gala this week, they were doing backflips, parkour, and full kung fu routines with nunchucks. Physical intelligence is moving faster than almost anyone expected. Source: CGTN

Must Read!

@Canon_India @CanonIndia Complaint CSP/20260206/97383 closed again as “Out of Scope” despite persistent paper jam issue. New complaint: CSP/20260211/39281 (11 Feb 2026). Urgent senior intervention or replacement required. @Canon

@drprasad77 @CanonIndia Hi Prasad, we're here to help. Kindly elaborate on your concern via DM. Our team will get back to you. twitter.com/messages/compo…

Extremely disappointed with @CanonIndia. My Canon inkjet printer (purchased July 2025) has had persistent paper jam issues since day one. @Canon ⬇️

He literally explained the Black Coffee Theory and why it changes how you approach life.

Service request no: CSP/20260206/97383. Requesting urgent senior technical inspection and permanent resolution. If unresolved, replacement should be considered. This level of service is unacceptable from a reputed brand. #CustomerService #CanonIndia @jagograhakjago

The printer is used in my medical clinic for generating patient prescriptions. Repeated failures disrupt clinical workflow. Despite service visits, the issue persists and complaints are closed as “out of scope”, wrongly blaming the paper. ⬇️